Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 1,316 | 1,236 | 1,174 | 1,887 | 1,199 |
| Gross Profit | 1,316 | 1,236 | 1,174 | 1,887 | 1,199 |
| Operating Expenses | 6,819 | 9,208 | 5,271 | 6,880 | 6,424 |
| Operating Income | -5,503 | -7,972 | -4,097 | -4,993 | -5,225 |
| Other Income | -1,357 | -1,596 | 8,567 | -1,537 | 2,180 |
| Pre-tax Income | -6,860 | -9,568 | 4,470 | -6,530 | -3,045 |
| Net Income Continuous | -6,860 | -9,568 | 4,470 | -6,530 | -3,045 |
| Net Income | $-6,860 | $-9,568 | $4,470 | $-6,530 | $-3,045 |
| EPS Basic Total Ops | -1,474.15 | -2,178.22 | 1,012.10 | -1,474.15 | -682.07 |
| EPS Basic Continuous Ops | -1,474.70 | -2,160.17 | 1,010.06 | -1,478.44 | -689.76 |
| EPS Diluted Total Ops | -1,474.15 | -2,156.22 | 990.10 | -1,474.15 | -682.07 |
| EPS Diluted Continuous Ops | -1,474.70 | -2,129.30 | 979.19 | -1,478.44 | -689.76 |
| EBITDA(a) | $-5,484 | $-7,953 | $-4,078 | $-4,975 | $-5,206 |